<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="44671">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02524756</url>
  </required_header>
  <id_info>
    <org_study_id>LNS-RH</org_study_id>
    <nct_id>NCT02524756</nct_id>
  </id_info>
  <brief_title>Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy</brief_title>
  <official_title>Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Osama Mohammad Ali ElDamshety</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess:

        1. Evaluation of the feasibility of laparoscopic nerve sparing radical hysterectomy type
           III/C1 as regard surgical technique, blood loss and operative time.

        2. Evaluate patients' outcome as regard bladder function and quality of life.

      in order to preserve the function of the bladder and the rectum, it is necessary to modify
      the traditional procedures, so as to identify the precise anatomical information directing
      the technique for optimal preservation of bladder function at the time of radical
      hysterectomy.

      The laparoscopic technique offers several well-known advantages. Under the magnified view of
      the laparoscope, the anatomy can be clearly visualized to allow for the meticulous and
      precise dissection of the para-cervical structures and areolar tissue, including the blood
      vessels and the nerves.

      Laparoscopic identification (neurolysis) of the inferior hypogastric nerve and inferior
      hypogastric plexus is a feasible procedure for trained laparoscopic surgeons who have a good
      knowledge not only of the retroperitoneal anatomy but also of the pelvic neuro-anatomy as
      this qualification could prohibit long-term bladder and voiding dysfunction during
      nerve-sparing radical hysterectomy
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of laparoscopic nerve sparing radical hysterectomy type III/C1</measure>
    <time_frame>day of surgery</time_frame>
    <description>Number of Patients in which the Laparoscopic nerve sparring hysterectomy can be done without laparotomy conversion and without nerve injury.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>bladder function</measure>
    <time_frame>1 months postoperative</time_frame>
    <description>Number of patients with Urinary bladder function problems after the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>Day of surgery</time_frame>
    <description>Amount of blood intraoperative blood loss in ml. units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>Day of surgery</time_frame>
    <description>Minutes for the surgical intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 month postoperative</time_frame>
    <description>Score of quality of life assessment postoperative</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cervical Cancer</condition>
  <arm_group>
    <arm_group_label>Group (A)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>laparoscopic nerve sparing radical hysterectomy type III/C1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group (B)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>laparoscopic radical hysterectomy type III/C2</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic nerve-sparing radical hysterectomy-type III/C1</intervention_name>
    <arm_group_label>Group (A)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic radical hysterectomy (type III/C2).</intervention_name>
    <arm_group_label>Group (B)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 18 years.

          2. Karnofsky &gt; 80, or American Society of anaethesiology (ASA) I-II

          3. No evidence of node involvement in preoperative MRI

          4. Stage IA2-IB1-IB2-IIA1-IIA2-IIB cervical cancer according to FIGO (International
             Federation of Gynecology and Obstetrics) staging.

          5. Body mass index (BMI) &lt; 35.

        Exclusion Criteria:

          1. Non Invasive Cancer

          2. Pregnancy

          3. Bladder dysfunction detected prior to surgery.

          4. Previous pelvic lymphadenectomy.

          5. Tumour recurrence

          6. Incomplete surgery, unresectable lesion.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khaled Gaballa, MS.c.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Lecturer of surgical oncology, Mansoura universitry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adel Taha Denewar, M.D., Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Head of surgical oncology department, Mansoura oncology centre, Mansoura university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giovanni Scambia, M.D.,Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Head of the Department for Woman and Unborn Life Health Care- Catholic University of the Sacred Heart- Rome, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>August 13, 2015</lastchanged_date>
  <firstreceived_date>August 12, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Osama Mohammad Ali ElDamshety</investigator_full_name>
    <investigator_title>surgical oncology</investigator_title>
  </responsible_party>
  <keyword>nerve sparing radical hysterectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
